Tempest Therapeutics
Development-stage biotechnology company.
Launch date
Employees
Market cap
$36.6m
Enterprise valuation
$26m (Public information from Sep 2024)
Share price
$1.41 TPST
San Francisco California (HQ)
Authorizing premium user...